Soltel, with its active ingredient salmeterol, is a long-acting beta2-adrenergic receptor agonist (LABA) used in the management of asthma and chronic obstructive pulmonary disease (COPD). It works by relaxing the muscles in the airways, thereby opening them and making it easier to breathe. Soltel is typically prescribed as a maintenance treatment rather than a rescue therapy and is often used in combination with inhaled corticosteroids to control and prevent symptoms such as wheezing and shortness of breath. It is important to note that Soltel is not intended for the relief of acute bronchospasm or as a first-line treatment for asthma or COPD, but rather as part of a long-term management plan.